Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy
Pharmaceutics · 10.06.2023 · 15 (6) · 1704
DOI: 10.3390/pharmaceutics15061704 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 10.06.2023. Verfasst von Rui Silva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FEDER funds, Fundação para a Ciência e Tecnologia (FCT), Portuguese Agency for Scientific Research.
Abstract (Originalsprache)
Perampanel is a promising antiepileptic drug (AED) for refractory epilepsy treatment due to its innovative mechanism of action. This study aimed to develop a population pharmacokinetic (PopPK) model to be further used in initial dose optimization of perampanel in patients diagnosed with refractory epilepsy. A total of seventy-two plasma concentrations of perampanel obtained from forty-four patients were analyzed through a population pharmacokinetic approach by means of nonlinear mixed effects modeling (NONMEM). A one-compartment model with first-order elimination best described the pharmacokinetic profiles of perampanel. Interpatient variability (IPV) was entered on clearance (CL), while the residual error (RE) was modeled as proportional. The presence of enzyme-inducing AEDs (EIAEDs) and body mass index (BMI) were found as significant covariates for CL and volume of distribution (V), respectively. The mean (relative standard error) estimates for CL and V of the final model were 0.419 L/h (5.56%) and 29.50 (6.41%), respectively. IPV was 30.84% and the proportional RE was 6.44%. Internal validation demonstrated an acceptable predictive performance of the final model. A reliable population pharmacokinetic model was successfully developed, and it is the first enrolling real-life adults diagnosed with refractory epilepsy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
- CIBIT/ICNAS-Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3000-548 Coimbra, Portugal.
- Farmacoteràpia, Farmacogenètica i Tecnologia Farmacèutica, IDIBELL-Institut d'Investigació Biomèdica de Bellvitge, 08907 Hospitalet de Llobregat, Spain.
- Pharmacy and Pharmaceutical Technology and Physical Chemistry Department, Universitat de Barcelona, 08028 Barcelona, Spain.
- CIVG-Vasco da Gama Research Center, EUVG-Vasco da Gama University School, 3020-210 Coimbra, Portugal.
- Refractory Epilepsy Reference Centre, Centro Hospitalar e Universitário de Coimbra, EPE, 3004-561 Coimbra, Portugal.
ORCID-Profile: Rui Silva, Joana Bicker, Anabela Almeida, Amílcar Falcão, Ana Fortuna
Förderung
- FEDER funds
- Fundação para a Ciência e Tecnologia (FCT), Portuguese Agency for Scientific Research
Zitieren
APA
Silva, R., Colom, H., Bicker, J., Almeida, A., Silva, A., Sales, F., Santana, I., Falcão, A., & Fortuna, A. (2023). Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy. Pharmaceutics, 15(6), 1704. https://doi.org/10.3390/pharmaceutics15061704
Vancouver
Silva R, Colom H, Bicker J, Almeida A, Silva A, Sales F, et al. Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy. Pharmaceutics. 2023;15(6):1704. doi:10.3390/pharmaceutics15061704
BibTeX
@article{Silva2023,
author = {Silva, Rui and Colom, Helena and Bicker, Joana and Almeida, Anabela and Silva, Ana and Sales, Francisco and Santana, Isabel and Falcão, Amílcar and Fortuna, Ana},
title = {Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {6},
pages = {1704},
doi = {10.3390/pharmaceutics15061704}
}
EUVIMED